calocurb glp-1 activator Calocurb® CLINICAL Starter Pack Calocurb® (by Ortho Molecular Products):

New developments in the treatment of schizophrenia: an expert roundtable

a.A.FarooquiF.HammamyM

While GLP-1s are cost-effective for those with diabetes, for those with obesity, these medications are not cost-effective at current prices

Because of the ever-expanding use of GLP-1 receptor agonists, the availability of an oral agent within this therapeutic class has the potential to further increase GLP-1 receptor agonist use and provide an alternative route of administration for patients unable or unwilling to take SC injections

Common side effects include loss of appetite, nausea, vomiting, diarrhea, and gastrointestinal discomfort

Sahu, K